Abstract
Immunohistochemical methods have been used for the diagnosis and management of chronic viral hepatitis. Today their use in clinical practice is more limited. This is due to improvement in diagnostic methods, less need and desire to perform a liver biopsy, and advances in assessment of liver disease severity by noninvasive means. Antibodies developed for immunohistochemistry (IHC) have applications far beyond IHC and are applicable to various methods including ELISA, immunofluorescence, immunoprecipitation, flow cytometry, immunocytochemistry, and Western blotting. Such methods have contributed to our understanding of the biology and function of several viral proteins. However, IHC staining may still have a role for the diagnosis and management of some viral hepatitis forms such as HDV and CMV infections. This holds true especially in the posttransplant setting, where IHC is a useful adjunct for the diagnosis and management of active CMV infection and for the assessment of latent HDV infection.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CHB:
-
Chronic hepatitis B
- CMV:
-
Cytomegalovirus
- HAV:
-
Hepatitis A virus
- HBcAg:
-
Hepatitis B core antigen
- HBeAg:
-
Hepatitis B early antigen
- HBsAg:
-
Hepatitis B surface antigen
- HBV DNA:
-
Hepatitis b virus DNA
- HDAg:
-
Hepatitis D antigen
- HDV RNA:
-
Hepatitis D virus RNA
- IHC:
-
Immunohistochemistry
References
Angiari S, Donnarumma T, Rossi B, et al. TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunity. Immunity. 2014;40:542–53.
Callea F. Immunohistochemical techniques for the demonstration of viral antigens in liver tissue. Ric Clin Lab. 1997;18:223–31.
Castera L, Denis J, Babany G, Roudot-Thoraval F. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines? J Hepatol. 2007;46:528–9.
Chu CM, Liaw YF. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. Gastroenterology. 1987;92:220–5.
Chu CM, Liaw YF. Immunohistological study of intrahepatic expression of hepatitis B core and E antigens in chronic type B hepatitis. J Clin Pathol. 1992a;45:791–5.
Chu CM, Liaw YF. Intrahepatic expression of hepatitis B core and surface antigens in chronic hepatitis delta-virus infection. J Hepatol. 1992b;16:153–8.
Chu CM, Yeh CT, Chien RN, et al. The degrees of hepatocyte nuclear but not cytoplasmic expression of hepatitis B core antigen reflects the level of viral replication in chronic hepatitis B virus infection. J Clin Microbiol. 1997;35:102–5.
Colina F, Juca NT, Moreno E, et al. Histological diagnosis of cytomegalovirus hepatitis in liver allografts. J Clin Pathol. 1995;48:351–7.
Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8:698–709.
Dalton HR, Bendall R, Keane F, Tedder R, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361:1025–7.
EASL Clinical Practice Guidelines. Management of chronic hepatitis B virus infection. J Hepatol. 2012;57:167–85.
EASL Recommendations on Treatment of Hepatitis C. 2015;63:199–236.
Feigelstock D, Thompson P, Mattoo P, et al. The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J Virol. 1998;72:6621–8.
Ghandi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis. 2004;4:725–38.
Hadziyannis S. Milestones and perspectives in viral hepatitis B. Liver Int. 2011;31 Suppl 1:129–34.
Kabaçam G, Wedemeyer H, Savas B, et al. Role of immunohistochemistry for hepatitis D and hepatitis B virus in hepatitis delta. Liver Int. 2011;34:1207–15.
Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811–7.
Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27:116–38.
Karma N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140:1481–9.
Kondratowicz AS, Lennemann NJ, Sinn PL, et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc Natl Acad Sci U S A. 2011;108:8426–31.
Kotton CN, Kumar D, Caliendo AM, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96:333.
Lee HH, Meyer EE, Goya S, et al. Apoptotic cells activate NKT cells through T cell Ig-like mucin-like–1 resulting in airway hyperreactivity. J Immunol. 2010;185:5225–35.
Levrero M, Pollicino T, Peterson J, et al. Control of cccDNA function in hepatitis B virus infection. J Hepatol. 2009;51:581–92.
Lu DYL, Qian J, Easley K, et al. Automated in situ hybridization and immunohistochemistry for cytomegalovirus detection in paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol. 2009;17:158–64.
Mathiesen LR, Feinstone SM, Purcell RH, et al. Detection of hepatitis A antigen by immunofluorescence. Infect Immun. 1977;18:524.
McIntire JJ, Umetsu SE, Akbari O, et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol. 2001;2:1109–16.
Mederacke I, Filmann N, Yurdaydin C, et al. Rapid early HDV RNA decline in the peripheral blood but prolonged intrahepatic hepatitis delta antigen persistence after liver transplantation. J Hepatol. 2012;56:115–22.
Meertens L, Carnec X, Lecoin MP, et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe. 2012;12:544–57.
Mondelli M, Tedder RS, Ferns B, et al. Differential distribution of hepatitis B core and E antigens in hepatocytes: analysis by monoclonal antibodies. Hepatology. 1986;2:199–204.
Neuveut C, Wei Y, Buendia MA. Mechanisms of HBV-related hepatocarcinogenesis. J Hepatol. 2010;52:594–604.
Rizzetto M. HDV: 30 years after. J Hepatol. 2009;50:1043–50.
Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18:997–1003.
Sansonno DE, Fiore G, Bufano G, et al. Cytoplasmic localization of hepatitis B core antigen in hepatitis B virus infected livers. J Immunol Methods. 1988;109:245–52.
Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev. 2000;64:51–68.
Serinoz E, Varli M, Erden E, et al. Nuclear localization of hepatitis B core antigen and its relations to liver injury, hepatocyte proliferation, and viral load. J Clin Gastroenterol. 2003;36:269–72.
Thompson AJV, Nguyen T, Iser D, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology. 2010;51:1933–44.
Webster DP, Klenerman P, Dusheiko GM. Hepatitis C. Lancet. 2015;385:1124.
Xiao S, Brooks CR, Zhu C, et al. Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc Natl Acad Sci U S A. 2012;109:12105–10.
Xiao S, Brooks CR, Sobel RA, et al. Tim-1 is essential for induction and maintenance of IL-10 in regulatory B cells and their regulation of tissue inflammation. J Immunol. 2015;194:1602–8.
Yurdaydin C, Idilman R, Bozkaya H, Bozdayi AM. Natural history and treatment of chronic delta hepatitis. J Viral Hepat. 2011;17:749–56.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media B.V.
About this entry
Cite this entry
Yurdaydin, C. (2017). Immunohistochemistry for Viral Hepatitis: Methods and Applications. In: Patel, V., Preedy, V. (eds) Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7675-3_45
Download citation
DOI: https://doi.org/10.1007/978-94-007-7675-3_45
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7674-6
Online ISBN: 978-94-007-7675-3
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences